Clinical Trials match your criteria
-
Retrospective Analysis of Adaptive Planning in ViewRay Treatments for Evaluation of Adaptive Plan Efficiency and its Impact on Dosimetry
Retrospective Analysis of Adaptive Planning in ViewRay Treatments for Evaluation of Adaptive Plan Efficiency and its Impact on Dosimetry
-
Circulating Tumor DNA as an Independent Predictor of treatment response in Metastatic Melanoma Patients Treated with Intratumoral and Cellular Therapies: A Retrospective Review
Circulating Tumor DNA as an Independent Predictor of Treatment Response in Metastatic Melanoma Patients Treated with Intratumoral and Cellular Therapies: A Retrospective Review
-
Retrospective Analysis of Outpatient Chemotherapy Administration and Subsequent Unplanned Emergency Department or Inpatient Admissions
Retrospective Analysis of Outpatient Chemotherapy Administration and Subsequent Unplanned Emergency Department or Inpatient Admissions
-
A Study of TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors (STARLING)
A Phase 1b Study of TBio-4101 (Autologous Selected and Expanded Tumor-Infiltrating Lymphocytes [TIL]) and Pembrolizumab in Patients with Advanced Solid Tumor Malignancies (STARLING)
-
Incidence of Surgical Site Complications Following Cesarean Delivery Closure Comparing Absorbable Subcuticular Staples with Conventional Closure
Incidence of Surgical Site Complications Following Cesarean Delivery Closure Comparing Absorbable Subcuticular Staples with Conventional Closure
-
Observational Advanced Age Study for RMS Patients Treated with Cladribine Tablets
A Multicenter, Observational Study to Characterize the Clinical Course in a Real-World, US Cohort of Patients with Relapsing Multiple Sclerosis of Advanced Age (≥ 50 years) Treated with Cladribine Tablets
-
Phase 2, Magrolimab plus FOLFIRI/BEV in mCRC
A Phase 2, Randomized, Open-Label Study Evaluating the Safety and Efficacy of Magrolimab in Combination With Bevacizumab and FOLFIRI Versus Bevacizumab and FOLFIRI in Previously Treated Advanced Inoperable Metastatic Colorectal Cancer (CRC)
-
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
Phase 1/2 Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants with Advanced Solid Tumors
-
Retrospective Analysis of Power Utilization in Radiation Therapy and its Ecological Footprint
Retrospective Analysis of Power Utilization in Radiation Therapy and its Ecological Footprint
-
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
A Phase 1/2, Open-Label, Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity Study of Repotrectinib in Pediatric and Young Adult Subjects With Advanced or Metastatic Malignancies Harboring ALK, ROS1, NTRK1-3 Alterations
